 |
|
Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants
Welmoed E. E. Meijer, PhD;
Eibert R. Heerdink, PhD;
Willem A. Nolen, MD, PhD;
Ron M. C. Herings, PhD;
Hubert G. M. Leufkens, PharmD;
Antoine C. G. Egberts, PharmD
Arch Intern Med. 2004;164:2367-2370.
Background Serotonin plays a role in platelet aggregation. Because antidepressants influence blood serotonin levels, their use may be associated with an increased risk of abnormal bleeding. However, previous studies were inconclusive regarding this association. The aim of this study was to estimate the risk of abnormal bleeding associated with the use of antidepressants and to establish the relationship between serotonin reuptake inhibition and the risk of bleeding.
Methods We used data collected from 1992 through 2000 to conduct a nested case-control study of a cohort of more than 64 000 new antidepressant users. Cases were identified as all patients hospitalized for a primary diagnosis of abnormal bleeding, and they were matched with controls for age and sex. We classified exposure according to the degree (high, intermediate, or low) of serotonin reuptake inhibition and performed logistic regression analysis to calculate odds ratios.
Results There were 196 cases of abnormal bleeding. The risk of hospitalization increased with the use of inhibitors providing intermediate (odds ratio, 1.9; 95% confidence interval, 1.1-3.5) and high degrees of serotonin reuptake inhibition (odds ratio, 2.6; 95% confidence interval, 1.4-4.8).
Conclusions In a large population of new antidepressant users we found a significant association between degree of serotonin reuptake inhibition by antidepressants and risk of hospital admission for abnormal bleeding as the primary diagnosis. An increased risk of abnormal bleeding was strongly associated with the degree of serotonin reuptake inhibition.
Author Affiliations: Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (Drs Meijer, Heerdink, Herings, Leufkens, and Egberts) and Kendle International (Dr Meijer), Utrecht, the Netherlands; Department of Psychiatry, University Hospital Groningen, Groningen, the Netherlands (Dr Nolen); PHARMO Institute for Drug Outcome Research, Utrecht (Dr Herings); Hospital Pharmacy Midden-Brabant, TweeSteden and St Elisabeth Hospital, Tilburg, the Netherlands (Dr Egberts).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Antidepressants, antiplatelets and bleeding: One more thing to worry about?
Juurlink
CMAJ 2011;183:1819-1820.
FULL TEXT
Depression and Incident Stroke in Women
Pan et al.
Stroke 2011;42:2770-2775.
ABSTRACT
| FULL TEXT
Upper gastrointestinal bleeding in a patient receiving selective serotonin reuptake inhibitor
Athimulam et al.
BMJ Case Reports 2011;2011:bcr0120113741-bcr0120113741.
ABSTRACT
| FULL TEXT
Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake
Lopez-Vilchez et al.
Cardiovasc Res 2009;84:309-316.
ABSTRACT
| FULL TEXT
Antidepressants and bleeding
Al-Adwani
Adv. Psychiatr. Treat. 2009;15:319-319.
FULL TEXT
Use of antidepressants in pregnancy does not increase risk of postpartum haemorrhage
Heerdink
Evid. Based Ment. Health 2008;11:125-125.
FULL TEXT
Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy: Interaction With Nonsteroidal Anti-inflammatory Drugs and Effect of Acid-Suppressing Agents
de Abajo and Garcia-Rodriguez
Arch Gen Psychiatry 2008;65:795-803.
ABSTRACT
| FULL TEXT
Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins
Schalekamp et al.
Arch Intern Med 2008;168:180-185.
ABSTRACT
| FULL TEXT
Improving Detection of Adverse Effects of Marketed Drugs
Klein and O'Brien
JAMA 2007;298:333-334.
FULL TEXT
SSRIs and gastrointestinal bleeding
Paton and Ferrier
BMJ 2005;331:529-530.
FULL TEXT
|
